Blockade of angiotensin II with losartan attenuates transforming growth factor-β1 inducible gene-h3 (ßig-h3) expression in a model of chronic cyclosporine nephrotoxicity

Bo Kyung Sun, Can Li, Sun Woo Lim, Bum Soon Choi, Suk Hee Lee, In-San Kim, Yong Soo Kim, Byung Kee Bang, Chul Woo Yang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: We recently demonstrated that upregulation of the transforming growth factor (TGF)-β1 inducible gene-h3 (ßig-h3) is associated with tubulointerstitial fibrosis (TIF) in a rat model of chronic cyclosporine A (CsA) nephrotoxicity. This study investigated the association between ßig-h3 expression and TIF during losartan treatment in this model. Methods: Adult Sprague-Dawley rats kept on a salt-depleted diet (0.05% sodium) were treated daily for 4 weeks with vehicle (olive oil, 1 ml/kg), CsA (15 mg/kg) or both CsA and losartan (10 mg/kg in drinking water). The effect of losartan on ßig-h3 expression was evaluated using in situ hybridization, immunohistochemistry and immunoblotting. Histopathology, expressions of TGF-ß1 and intrarenal angiotensin II were compared across treatment groups. Results: Concurrent administration of losartan significantly attenuated ßig-h3 mRNA and protein expression within the tubulointerstitium of CsA-treated kidneys. This was accompanied by the retardation of TIF (18 ± 5 vs. 39 ± 5%, p < 0.01 vs. CsA) and the expression of TGF-β1 mRNA (336 ± 49 vs. 685 ± 63%, p < 0.01 vs. CsA) and the number of angiotensin II-positive glomeruli (18 ± 5 vs. 38 ± 6, p < 0.05 vs. CsA). Conclusion: Losartan is capable of abrogating the upregulation of TGF-β1 and ßig-h3 expression, and this is associated with attenuated tubulointerstitial fibrosis in chronic CsA nephrotoxicity.

Original languageEnglish
JournalNephron - Experimental Nephrology
Volume99
Issue number1
DOIs
Publication statusPublished - 2005 Feb 3
Externally publishedYes

Fingerprint

Losartan
Transforming Growth Factors
Angiotensin II
Cyclosporine
Gene Expression
Fibrosis
Up-Regulation
Messenger RNA
Immunoblotting
Drinking Water
Genes
In Situ Hybridization
Sprague Dawley Rats
Salts
Sodium
Immunohistochemistry
Diet
Kidney
Therapeutics

Keywords

  • Cyclosporine
  • Extracellular matrix
  • Fibrosis
  • Losartan
  • Renin angiotensin system
  • TGF-β1-inducible gene-h3
  • Transforming growth factor-β1

ASJC Scopus subject areas

  • Physiology
  • Genetics
  • Nephrology

Cite this

Blockade of angiotensin II with losartan attenuates transforming growth factor-β1 inducible gene-h3 (ßig-h3) expression in a model of chronic cyclosporine nephrotoxicity. / Sun, Bo Kyung; Li, Can; Lim, Sun Woo; Choi, Bum Soon; Lee, Suk Hee; Kim, In-San; Kim, Yong Soo; Bang, Byung Kee; Yang, Chul Woo.

In: Nephron - Experimental Nephrology, Vol. 99, No. 1, 03.02.2005.

Research output: Contribution to journalArticle

Sun, Bo Kyung ; Li, Can ; Lim, Sun Woo ; Choi, Bum Soon ; Lee, Suk Hee ; Kim, In-San ; Kim, Yong Soo ; Bang, Byung Kee ; Yang, Chul Woo. / Blockade of angiotensin II with losartan attenuates transforming growth factor-β1 inducible gene-h3 (ßig-h3) expression in a model of chronic cyclosporine nephrotoxicity. In: Nephron - Experimental Nephrology. 2005 ; Vol. 99, No. 1.
@article{f2d84d7f36f6408f9f546af33cb720da,
title = "Blockade of angiotensin II with losartan attenuates transforming growth factor-β1 inducible gene-h3 ({\ss}ig-h3) expression in a model of chronic cyclosporine nephrotoxicity",
abstract = "Background: We recently demonstrated that upregulation of the transforming growth factor (TGF)-β1 inducible gene-h3 ({\ss}ig-h3) is associated with tubulointerstitial fibrosis (TIF) in a rat model of chronic cyclosporine A (CsA) nephrotoxicity. This study investigated the association between {\ss}ig-h3 expression and TIF during losartan treatment in this model. Methods: Adult Sprague-Dawley rats kept on a salt-depleted diet (0.05{\%} sodium) were treated daily for 4 weeks with vehicle (olive oil, 1 ml/kg), CsA (15 mg/kg) or both CsA and losartan (10 mg/kg in drinking water). The effect of losartan on {\ss}ig-h3 expression was evaluated using in situ hybridization, immunohistochemistry and immunoblotting. Histopathology, expressions of TGF-{\ss}1 and intrarenal angiotensin II were compared across treatment groups. Results: Concurrent administration of losartan significantly attenuated {\ss}ig-h3 mRNA and protein expression within the tubulointerstitium of CsA-treated kidneys. This was accompanied by the retardation of TIF (18 ± 5 vs. 39 ± 5{\%}, p < 0.01 vs. CsA) and the expression of TGF-β1 mRNA (336 ± 49 vs. 685 ± 63{\%}, p < 0.01 vs. CsA) and the number of angiotensin II-positive glomeruli (18 ± 5 vs. 38 ± 6, p < 0.05 vs. CsA). Conclusion: Losartan is capable of abrogating the upregulation of TGF-β1 and {\ss}ig-h3 expression, and this is associated with attenuated tubulointerstitial fibrosis in chronic CsA nephrotoxicity.",
keywords = "Cyclosporine, Extracellular matrix, Fibrosis, Losartan, Renin angiotensin system, TGF-β1-inducible gene-h3, Transforming growth factor-β1",
author = "Sun, {Bo Kyung} and Can Li and Lim, {Sun Woo} and Choi, {Bum Soon} and Lee, {Suk Hee} and In-San Kim and Kim, {Yong Soo} and Bang, {Byung Kee} and Yang, {Chul Woo}",
year = "2005",
month = "2",
day = "3",
doi = "10.1159/000081793",
language = "English",
volume = "99",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Blockade of angiotensin II with losartan attenuates transforming growth factor-β1 inducible gene-h3 (ßig-h3) expression in a model of chronic cyclosporine nephrotoxicity

AU - Sun, Bo Kyung

AU - Li, Can

AU - Lim, Sun Woo

AU - Choi, Bum Soon

AU - Lee, Suk Hee

AU - Kim, In-San

AU - Kim, Yong Soo

AU - Bang, Byung Kee

AU - Yang, Chul Woo

PY - 2005/2/3

Y1 - 2005/2/3

N2 - Background: We recently demonstrated that upregulation of the transforming growth factor (TGF)-β1 inducible gene-h3 (ßig-h3) is associated with tubulointerstitial fibrosis (TIF) in a rat model of chronic cyclosporine A (CsA) nephrotoxicity. This study investigated the association between ßig-h3 expression and TIF during losartan treatment in this model. Methods: Adult Sprague-Dawley rats kept on a salt-depleted diet (0.05% sodium) were treated daily for 4 weeks with vehicle (olive oil, 1 ml/kg), CsA (15 mg/kg) or both CsA and losartan (10 mg/kg in drinking water). The effect of losartan on ßig-h3 expression was evaluated using in situ hybridization, immunohistochemistry and immunoblotting. Histopathology, expressions of TGF-ß1 and intrarenal angiotensin II were compared across treatment groups. Results: Concurrent administration of losartan significantly attenuated ßig-h3 mRNA and protein expression within the tubulointerstitium of CsA-treated kidneys. This was accompanied by the retardation of TIF (18 ± 5 vs. 39 ± 5%, p < 0.01 vs. CsA) and the expression of TGF-β1 mRNA (336 ± 49 vs. 685 ± 63%, p < 0.01 vs. CsA) and the number of angiotensin II-positive glomeruli (18 ± 5 vs. 38 ± 6, p < 0.05 vs. CsA). Conclusion: Losartan is capable of abrogating the upregulation of TGF-β1 and ßig-h3 expression, and this is associated with attenuated tubulointerstitial fibrosis in chronic CsA nephrotoxicity.

AB - Background: We recently demonstrated that upregulation of the transforming growth factor (TGF)-β1 inducible gene-h3 (ßig-h3) is associated with tubulointerstitial fibrosis (TIF) in a rat model of chronic cyclosporine A (CsA) nephrotoxicity. This study investigated the association between ßig-h3 expression and TIF during losartan treatment in this model. Methods: Adult Sprague-Dawley rats kept on a salt-depleted diet (0.05% sodium) were treated daily for 4 weeks with vehicle (olive oil, 1 ml/kg), CsA (15 mg/kg) or both CsA and losartan (10 mg/kg in drinking water). The effect of losartan on ßig-h3 expression was evaluated using in situ hybridization, immunohistochemistry and immunoblotting. Histopathology, expressions of TGF-ß1 and intrarenal angiotensin II were compared across treatment groups. Results: Concurrent administration of losartan significantly attenuated ßig-h3 mRNA and protein expression within the tubulointerstitium of CsA-treated kidneys. This was accompanied by the retardation of TIF (18 ± 5 vs. 39 ± 5%, p < 0.01 vs. CsA) and the expression of TGF-β1 mRNA (336 ± 49 vs. 685 ± 63%, p < 0.01 vs. CsA) and the number of angiotensin II-positive glomeruli (18 ± 5 vs. 38 ± 6, p < 0.05 vs. CsA). Conclusion: Losartan is capable of abrogating the upregulation of TGF-β1 and ßig-h3 expression, and this is associated with attenuated tubulointerstitial fibrosis in chronic CsA nephrotoxicity.

KW - Cyclosporine

KW - Extracellular matrix

KW - Fibrosis

KW - Losartan

KW - Renin angiotensin system

KW - TGF-β1-inducible gene-h3

KW - Transforming growth factor-β1

UR - http://www.scopus.com/inward/record.url?scp=12444292702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444292702&partnerID=8YFLogxK

U2 - 10.1159/000081793

DO - 10.1159/000081793

M3 - Article

C2 - 15637465

AN - SCOPUS:12444292702

VL - 99

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 1

ER -